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CONDITION AND PROSPECTS OF USE
OF THE SUBSIDIARY REPRODUCTIVE
TECHNOLOGIES IN THE TREATMENT
OF INFERTILITY UKRAINE
Abstract. In Ukraine in 2012, there were 44,707 cases of female and
male infertility 11941 (in 2011, respectively, 44071 and 12354 cases). In
2011 it has been made 12775 cycles of assisted reproductive technology
(ART) of infertility treatment (2010 - 11144), which consituted 360 per 1
million of population. Pregnancy rate per 100 initiated cycles of IVF in
Ukraine in 2011 amounted to 37.8% (in 2010 - 37.4%).
Keywords: infertility, assisted
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Introduction
The problem of diagnosis and treatment of infer-
tility remains relevant despite significant advances of
reproductive medicine [1]. The demographic situation
in Ukraine requires the improvement of new methods
of treatments for infertility [2]. Actively developing
methodology assisted reproductive technologies [3].
However, the frequency of their use in Ukraine
continues to be low, due to the lack of awareness about
the effectiveness of fertility treatment using these
technologies, low coverage of this issue in the media,
poor awareness of doctors regarding the use of
technology in the treatment of infertility [4, 5 7, 8, 9].
The purpose of study
Analysis of statistical information and documentation
about infertility and assisted reproductive technologies in
Ukraine from 1999 to 2012.
Material and methods
The analysis of statistical reports - form number 41
(“Report on assisted reproductive technology”,
approved by the Ministry of Health Ukraine 10.12.2001
¹ 489 and registered with the Ministry of Justice of
25.12.2001, ¹ 1068/6259) RS “Center for Health
Statistics, Ministry of Health of Ukraine”
Reports of health care, dealing with infertility
treatment methods of assisted reproductive
technologies are retrospective in nature and provide
an opportunity to analyze the outcomes of treatment
cycles started. So reports of treatment cycles started
in 1999 were granted in 2001, the year ... Of cycles
started in 2011, respectively, in 2013 financial year.
Discussion of results of the study
It is known that the incidence of female infertility
is 30% male - 30% blend - 30%, and of unknown
origin - 10% [6]. However, the structure of infertility
in Ukraine in 2011 is the following: 78.9% - female
infertility, 21.1% - male (Fig. 1).
According to government statistical reports in
Ukraine in 2012, there were 44,707 cases of female
infertility and 11941 cases of male infertility, in
2011, respectively, 44071 and 12354 cases. 12579
cases of female infertility and male - 3712 (in 2011,
respectively, 12566 and 4159 cases) were registered
for the first time in the life.
During 2001-2005, the frequency of male and
female infertility was registered almost at the same
level (Table 1). Since 2006, frequency of registration
of cases of male infertility has increased almost 2
times. However, the prevalence rate of female
infertility continues to be higher than in men (3.7
times in 2012). In women it is3.4 times higher than
in men, incidence, ie, newly diagnosed cases of
infertility in life.
Recorded frequency of infertility in some areas of
Ukraine varies in significant limits. The highest level
of female infertility diagnosis in 2012 was registered
in Zaporizhia - 17.24 (in 2011 - 15.53 per 1,000
women of childbearing age), Vinnytsia - 4.40 (in
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2011 - 4.20) and Volyn - 4.30 ( in 2011 - 4.11)
regions. The lowest level of female infertility
diagnosis was in Rivne - 2.27 (in 2011 - 2.40) and
Luhansk - 2.35 (in 2011 - 2.32) regions.
The highest rate of diagnosis of male infertility
during this period was registered in Zaporizhia -
12.44 (in 2011 - 11.15 1000 men of reproductive age)
and Odessa - 1.90 (in 2011 - 1.90) regions. The
lowest rate of diagnosis of male infertility has been
in Chernivtsi - 0.03 (in 2011 - 0.04 per 1000) region.
In Ukraine at the beginning of 2013 there are 36
medical institutions involved in fertility treatments,
including - 6 of state jurisdiction. All institutions are
the members of the Ukrainian Association of
Reproductive Medicine, except for two, “Family
Planning Clinics problems” (Kyiv) and clinic “Bio-
Tech-Com» (Kyiv). Each year, all medical
institutions that deal with subsidiary reproductive
technologies must render an account to the MoH
Ukraine Order number under 41 (National Register).
On the basis of these data formed a report to the
European Association of Human Reproduction and
Embryology (ESHRE) is formed.
In 2011, the cycles are not performed 3 Centers
for Human Reproduction: Clinical Reproductive
Medicine “VioTehSom” in Kyiv, Center for
Reproductive Medicine, “Bogolyubov” in Volyn
region, Zaporizhzhya Regional Rehabilitation Center
for reproductive rights in the Zaporozhye region.
Clinical problems of family planning (Kyiv) refused
to provide a report on cycles started in 1999, 2000,
2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008,
2009, 2010, 2011, respectively (Fig. 2).
In 2011, 12,775 treatment cycles were started,
during which the intended methods of infertility
treatment by means of subsidiary reproductive
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technologies and monitoring of follicle growth (Fig.
3) were intended to be carried out.
Within the cycles initiated in 2011 ICSI consti-
tuted to 45.9% (intracytoplasmic sperm) IVF - 24.4%
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(fertilization in vitro - IVF, previous period - in vitro
fertilization) cycles with transfer of cryopreserved
embryos - 17.8% (Crio), oocyte donation - 9,9%
(DO), MESA-TESE - 1,5% and cycles with embryo
biopsy - 0,5% (Biops. embr.) (Fig. 4). According to
the European Association of Human Reproduction
and Embryology (ESHRE) ICSI - cycles constituted
66.7% [5] in 2006.
Among the causes of infertility in cycles initiated in
2011 registered combined factors were registered in
33.96% of cases, tubal factor only - at 23.88%, the other
female factor - at 22.63%, only male factor - in 15.02%
and idiopathic infertility - in 4.06% of cases (Fig. 5).
Describing the age of patients itshould be noted
that among the initiated cycles 30-34 age group made
up the highest percentage (32.59%) last year,
followed by age group 35-39 years (27.61%) and 25-
29 years (19 , 23%). Patients aged over 40 accounted
for 17.09%, less than 25 years - 3.03%.
Pregnancy rate per 100 initiated cycles of IVF in
Ukraine in 2011 amounted to 37.8% (in 2010 -
37.4%) (Fig. 6).
The frequency of pregnancy IVF technology
distributed as follows: IVF - 38,95%, ICSI - 38,17%,
the transfer of cryopreserved embryos - 33.32%,
oocyte donation cycles - cycles of 41.35% and a
biopsy of the embryo - 26.32 % (Table 2).
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In 100 IVF cycles started in 2011 ectopic
pregnancy was marked in 0.56% of cases, an
abortion for medical reasons was in 0.31% of
patients, spontaneous abortion - in 5.67% of cases.
The deliveries with one living fetus were 22.16%,
two or more living fetuses were in 6,82 patients with
infertility (Table 3).
4568 babies were born alive after started in 2011
treatment cycles using subsidiary reproductive
technology, among them in term of 22-27 weeks - 52,
in terms of 28 weeks or more - 4516. Mortinatality
among infants born after started in 2011 treatment
cycles using subsidiary reproductive technologies
was 6.97 (in 2010 - 2.23) per 1000 live births and
dead (Table 4).
In total, 25014 alive children were born after using
treatment cycles by means of assisted reproductive
technologies since 1999, in Ukraine (Fig. 7).
Conclusion
The specific structure and a wide range of
fluctuations in the prevalence of male and female
infertility in some areas of Ukraine need to be paid
attention to the quality of professionals for diagnosis
and completeness of registration. The effectiveness
of assisted reproductive technologies in Ukraine is in
accordance with European indexes, but the number
of cycles is low. Violation MZ order of Ukraine by
medical institutions on reporting the use of ART is
accompanied by incomplete elucidation of the
achievements of our modern medicine in the field of
up-to-date fresh medical technology is inadmissible.
Prospects for further research
To continue work on formulating legal, economic
and scientific basis for the development of
reproductive medicine.
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